Insider Transactions in Q2 2020 at Merrimack Pharmaceuticals Inc (MACK)
Insider Transaction List (Q2 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 21
2020
|
Eric Andersen |
BUY
Open market or private purchase
|
Indirect |
1,424
+0.21%
|
$4,272
$3.25 P/Share
|
|
Apr 21
2020
|
Noah G. Levy Director |
BUY
Open market or private purchase
|
Indirect |
1,424
+0.12%
|
$4,272
$3.25 P/Share
|
|
Apr 20
2020
|
Eric Andersen |
BUY
Open market or private purchase
|
Indirect |
2,325
+0.34%
|
$6,975
$3.25 P/Share
|
|
Apr 20
2020
|
Noah G. Levy Director |
BUY
Open market or private purchase
|
Indirect |
2,325
+0.19%
|
$6,975
$3.25 P/Share
|
|
Apr 07
2020
|
Noah G. Levy Director |
BUY
Open market or private purchase
|
Indirect |
5,899
+0.49%
|
$17,697
$3.03 P/Share
|
|
Apr 07
2020
|
Eric Andersen |
BUY
Open market or private purchase
|
Indirect |
5,899
+0.85%
|
$17,697
$3.03 P/Share
|
|
Apr 06
2020
|
Noah G. Levy Director |
BUY
Open market or private purchase
|
Indirect |
6,042
+0.5%
|
$18,126
$3.0 P/Share
|
|
Apr 06
2020
|
Eric Andersen |
BUY
Open market or private purchase
|
Indirect |
6,043
+0.88%
|
$18,129
$3.0 P/Share
|
|
Apr 03
2020
|
Noah G. Levy Director |
BUY
Open market or private purchase
|
Indirect |
10,750
+0.9%
|
$21,500
$2.59 P/Share
|
|
Apr 03
2020
|
Eric Andersen |
BUY
Open market or private purchase
|
Indirect |
10,750
+1.56%
|
$21,500
$2.6 P/Share
|